We are live on ! Find out more
LCTX icon

Lineage Cell Therapeutics

68 hedge funds and large institutions have $134M invested in Lineage Cell Therapeutics in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 10

36% more capital invested

Capital invested by funds: $98.5M → $134M (+$35.3M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4.8% less ownership

Funds ownership: 49.66%44.86% (-4.8%)

8% less funds holding

Funds holding: 7468 (-6)

50% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 12

82% less call options, than puts

Call options by funds: $284K | Put options by funds: $1.55M

Holders
68
Holders Change
-6
Holders Change %
-8.11%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
25
Reduced
10
Closed
12
Calls
$284K
Puts
$1.55M
Net Calls
-$1.26M
Net Calls Change
-$867K
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
76
Citadel Advisors
Florida
-$12.6K -4,205 Closed
ST
77
Spot Trading
Illinois
-$10K -4,109 Closed
BAMS
78
Bellevue Asset Management (Switzerland)
Switzerland
-$2K -2,842 Closed
LFR
79
Lehman Financial Resources
Pennsylvania
-$3K -1,239 Closed